KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test
Introduction to the Test
The KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test is an advanced diagnostic tool designed to identify genetic mutations associated with benign neonatal seizures. This test utilizes Next-Generation Sequencing (NGS) technology to provide precise insights into the genetic factors that may contribute to neurological disorders in newborns. Understanding these genetic markers is crucial for early diagnosis and management, helping healthcare providers offer tailored treatment plans for affected infants.
What the Test Measures
This genetic test specifically measures mutations in the KCNQ3 gene, which plays a vital role in neuronal excitability. By analyzing the DNA samples, healthcare professionals can determine if there are any genetic predispositions to benign neonatal seizures, allowing for better clinical management of the condition.
Who Should Consider This Test?
Parents and caregivers should consider the KCNQ3 Gene Test if:
- The infant has experienced unexplained seizures during the neonatal period.
- There is a family history of seizures or neurological disorders.
- The healthcare provider recommends genetic testing based on clinical evaluation.
Benefits of Taking the Test
Taking the KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test offers several benefits:
- Early identification of genetic risks associated with neonatal seizures.
- Informed decision-making for treatment and management strategies.
- Support for families through genetic counseling and understanding of potential outcomes.
Understanding Your Results
Results from the KCNQ3 Gene Test will be provided within 3 to 4 weeks. A healthcare professional will explain the findings, including whether any mutations were detected, and what that means for the infant’s health. It’s essential to discuss these results in the context of the infant’s clinical history and family background.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Branches and Booking
We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu, ensuring that you have easy access to our services. We also offer home sample collection services for your convenience. To book the KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test, please call or WhatsApp us at +254746849631.
